Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

被引:100
作者
Lebrun, C. [1 ]
Bensa, C. [2 ]
Debouverie, M. [3 ]
De Seze, J. [4 ]
Wiertlievski, S. [5 ]
Brochet, B. [6 ]
Clavelou, P. [7 ]
Brassat, D. [8 ]
Labauge, P. [9 ]
Roullet, E. [2 ]
机构
[1] CHU Nice, Nice, France
[2] Hop Tenon, F-75970 Paris, France
[3] CHU Nancy, Nancy, France
[4] CHU Strasbourg, Strasbourg, France
[5] CHU Nantes, Nantes, France
[6] CHU Bordeaux, Bordeaux, France
[7] CHU Clermont Ferrand, Clermont Ferrand, France
[8] CHU Toulouse, Purpan, France
[9] CHU Nimes, Nimes, France
关键词
DIAGNOSTIC-CRITERIA; PREDICT CONVERSION; MRI CRITERIA; DEFINITE; DISABILITY;
D O I
10.1136/jnnp.2006.108274
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The concept of preclinical multiple sclerosis is now well recognised, and a diagnosis of silent brain T2 lesions is frequent because of the ease of performing MRI. Nevertheless, patients with incidental brain MRI fulfilling Barkhof- Tintore criteria are more rare. We report a descriptive retrospective study of clinical and 5 year MRI follow-up in patients with subclinical demyelinating lesions fulfilling MRI Barkhof- Tintore criteria with a normal neurological examination. 30 patients were identified and the first brain MRI was performed for various medical events: headaches (n = 14), migraine with (n = 2) or without (n = 4) aura, craniocerebral trauma (n = 3), depression (n = 3), dysmenorrhoea (n = 2), epilepsy (n = 1) and cognitive changes (n = 1). Mean time for the second brain MRI was 6 months (range 3-30). 23 patients had temporospatial dissemination (eight with gadolinium enhancement). 11 patients had clinical conversion: optic neuritis (n = 5), brainstem (n = 3), sensitive symptoms (n = 2) and cognitive deterioration (n = 1). Eight (72%) already had criteria of dissemination to space and time before the clinical event. Mean time between the first brain MRI and clinically isolated syndrome (CIS) was 2.3 years. To our knowledge, this is the first cohort of CIS with preclinical follow-up. Early treatment should be discussed in view of the predictive value on conversion of the MRI burden of the disease.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 20 条
[1]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[2]   A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].
Brex, PA ;
Ciccarelli, O ;
O'Riordan, JI ;
Sailer, M ;
Thompson, AJ ;
Miller, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164
[3]  
CASTAIGNE P, 1981, REV NEUROL-FRANCE, V137, P729
[4]   Relapses and progression of disability in multiple sclerosis. [J].
Confavreux, C ;
Vukusic, S ;
Moreau, T ;
Adeleine, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1430-1438
[5]   Sequential magnetic resonance imaging follow-up of multiple sclerosis before the clinical phase [J].
de Seze, J ;
Vermersch, P .
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (04) :395-397
[6]   Immunomodulatory agents for the treatment of relapsing multiple sclerosis [J].
Galetta, SL ;
Markowitz, C ;
Lee, AG .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2161-2169
[7]   UNSUSPECTED MULTIPLE-SCLEROSIS [J].
GILBERT, JJ ;
SADLER, M .
ARCHIVES OF NEUROLOGY, 1983, 40 (09) :533-536
[8]   MULTIPLE-SCLEROSIS - THE SPECTRUM OF SEVERITY [J].
HERNDON, RM ;
RUDICK, RA .
ARCHIVES OF NEUROLOGY, 1983, 40 (09) :531-532
[9]   Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].
Jacobs, LD ;
Beck, RW ;
Simon, JH ;
Kinkel, RP ;
Brownscheidle, CM ;
Murray, TJ ;
Simonian, NA ;
Slasor, PJ ;
Sandrock, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904
[10]   Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes [J].
Kappos, L. ;
Polman, C. H. ;
Freedman, M. S. ;
Edan, G. ;
Hartung, H. P. ;
Miller, D. H. ;
Montalban, X. ;
Barkhof, F. ;
Bauer, L. ;
Jakobs, P. ;
Pohl, C. ;
Sandbrink, R. .
NEUROLOGY, 2006, 67 (07) :1242-1249